William A. Backus - Jul 30, 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
VP & Chief Accounting Officer
Signature
/s/ Travis Larsen, Attorney in Fact for William A Backus
Stock symbol
BCPC
Transactions as of
Jul 30, 2024
Transactions value $
-$531,609
Form type
4
Date filed
8/1/2024, 06:09 PM
Previous filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Options Exercise $328K +3.9K +78.19% $84.09 8.89K Jul 30, 2024 Direct F1
transaction BCPC Common Stock Sale -$640K -3.57K -40.17% $179.25 5.32K Jul 30, 2024 Direct F2
transaction BCPC Common Stock Sale -$59.6K -330 -6.21% $180.47 4.99K Jul 30, 2024 Direct F3
transaction BCPC Common Stock Sale -$160K -904 -87.26% $177.10 132 Jul 30, 2024 401(k) Plan F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Options (right to buy) Options Exercise $0 -3.9K -100% $0.00* 0 Jul 30, 2024 Common Stock 3.9K $84.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of fully vested non-qualified stock options.
F2 This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F3 This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4 Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.
F5 Reflects shares previously acquired under the Balchem Corporation 401(k) plan.
F6 Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.